SMG1 and Waldenstrom macroglobulinemia: Furthermore, SMG1 inhibitors might be effective in other malignancies that depend on the UPR for survival such as Waldenström's macroglobulinemia, acute myeloid leukemia (AML), as well as other solid tumor types.